Deborah Dauber's guest appearances

Deborah Dauber

iBiology Career and Professional Development

Freeman Hrabowski

David Burgess

Jessica Tashker

Christine Siu

Joanne Kamens

Ronald Germain

Chris Tachibana

Ben Barres

Jon Lorsch

Janet Woodcock

Gregory Petsko

Kishore Hari

Malcolm Campbell

Anatol Kreitzer

Keith Yamamoto

OwlTail

https://www.ibiology.org/playlists/business-concepts-scientists-courseThe Business Concepts for Biomedical Scientists (BCBS) course (5 modules, 13 videos) is unique because it is designed to prepare scientists for career transitions into both academic and non-academic settings. The modules include Business Strategy, Finance, Business Development, Strategic Collaborations, and Strategic Toolkits. This Strategic Toolkits module is designed provide an overview of tools used to develop and assess strategy, and use examples to illustrate the concepts. Participants will learn and apply frameworks such as SWOT or PEST analyses to evaluate an operating environment including competitors, stakeholders, supplies, and economic, regulatory or technology trends. Participants will also learn about tools to help set, generate, and prioritize an enterprise's goals.Speaker Biography:Deborah Dauber has a Ph.D. in Chemistry and Chemical Biology from UCSF and a Master’s in Public Health with a focus in Health Policy &amp; Management from UC Berkeley.  She has 15 years of experience in pharmaceutical market analysis and strategy.  Currently consulting with a focus in pharmaceutical competitive analysis, Deborah works with biotech firms to make informed business decisions based on in-depth assessment of competitors in development and on the market.  Prior to that, Deborah was head of CI for Genentech, and led competitive intelligence initiatives to investigate key competitors (product and company-level), evaluate revenue impact of competition, and assess full market landscapes.

<a href="https://www.ibiology.org/playlists/business-concepts-scientists-course" rel="nofollow" target="_blank">https://www.ibiology.org/playlists/business-concepts-scientists-course</a> The Business Concepts for Biomedical Scientists (BCBS) course (5 modules, 13 videos) is unique because it is designed to prepare scientists for career transitions into both academic and non-academic settings. The modules include Business Strategy, Finance, Business Development, Strategic Collaborations, and Strategic Toolkits. This Strategic Toolkits module is designed provide an overview of tools used to develop and assess strategy, and use examples to illustrate the concepts. Participants will learn and apply frameworks such as SWOT or PEST analyses to evaluate an operating environment including competitors, stakeholders, supplies, and economic, regulatory or technology trends. Participants will also learn about tools to help set, generate, and prioritize an enterprise's goals. Speaker Biography: Deborah Dauber has a Ph.D. in Chemistry and Chemical Biology from UCSF and a Master’s in Public Health with a focus in Health Policy &amp; Management from UC Berkeley. She has 15 years of experience in pharmaceutical market analysis and strategy. Currently consulting with a focus in pharmaceutical competitive analysis, Deborah works with biotech firms to make informed business decisions based on in-depth assessment of competitors in development and on the market. Prior to that, Deborah was head of CI for Genentech, and led competitive intelligence initiatives to investigate key competitors (product and company-level), evaluate revenue impact of competition, and assess full market landscapes.

BCBS: Strategic Toolkits 2 - Toolkit for Developing Strategy (Deborah Dauber)

BCBS: Strategic Toolkits 1 - Environmental Assessment Toolkit (Deborah Dauber)

https://www.ibiology.org/playlists/business-concepts-scientists-courseThe Business Concepts for Biomedical Scientists (BCBS) course (5 modules, 13 videos) is unique because it is designed to prepare scientists for career transitions into both academic and non-academic settings. The modules include Business Strategy, Finance, Business Development, Strategic Collaborations, and Strategic Toolkits. This Business Strategy module is designed to teach bench researchers how scientists develop and execute strategy. Content includes an overview of how scientific enterprises use business strategy such as determining value proposition, identifying stakeholders, and defining vision. Concepts will be reinforced using practical examples from academic and industry settings.Speaker Biographies:Deborah Dauber has a Ph.D. in Chemistry and Chemical Biology from UCSF and a Master’s in Public Health with a focus in Health Policy &amp; Management from UC Berkeley.  She has 15 years of experience in pharmaceutical market analysis and strategy.  Currently consulting with a focus in pharmaceutical competitive analysis, Deborah works with biotech firms to make informed business decisions based on in-depth assessment of competitors in development and on the market.  Prior to that, Deborah was head of CI for Genentech, and led competitive intelligence initiatives to investigate key competitors (product and company-level), evaluate revenue impact of competition, and assess full market landscapes.Sandra Waugh Ruggles is a healthcare innovator and strategic marketer.  Currently focused on consulting for small companies seeking to design and develop novel medical devices, Sandy was formerly in strategic marketing at Acclarent (part of J&amp;J).  She holds a PhD from UCSF in Biophysics, and was a Thomas Fogarty Fellow at the Stanford Biodesign program.  Her first company, Catalyst Biosciences was formed in part from her thesis at UCSF, and is now a clinical stage, NASDAQ listed company.Anatol Kreitzer, PhD is an Associate Investigator at the Gladstone Institute of Neurological Disease and Associate Professor of Physiology and Neurology at UCSF.  Dr. Kreitzer’s research focuses on the disordered physiological processes associated with Parkinson’s disease.  He is an expert in the emerging field of optogenetics—the application of genetic and optical techniques to remotely control brain cells in animals.  Dr. Kreitzer earned his PhD in neurobiology at Harvard University.  He conducted postdoctoral research at Stanford University with Dr. Robert Malenka until 2007, when he established his laboratory at Gladstone.

<a href="https://www.ibiology.org/playlists/business-concepts-scientists-course" rel="nofollow" target="_blank">https://www.ibiology.org/playlists/business-concepts-scientists-course</a> The Business Concepts for Biomedical Scientists (BCBS) course (5 modules, 13 videos) is unique because it is designed to prepare scientists for career transitions into both academic and non-academic settings. The modules include Business Strategy, Finance, Business Development, Strategic Collaborations, and Strategic Toolkits. This Business Strategy module is designed to teach bench researchers how scientists develop and execute strategy. Content includes an overview of how scientific enterprises use business strategy such as determining value proposition, identifying stakeholders, and defining vision. Concepts will be reinforced using practical examples from academic and industry settings. Speaker Biographies: Deborah Dauber has a Ph.D. in Chemistry and Chemical Biology from UCSF and a Master’s in Public Health with a focus in Health Policy &amp; Management from UC Berkeley. She has 15 years of experience in pharmaceutical market analysis and strategy. Currently consulting with a focus in pharmaceutical competitive analysis, Deborah works with biotech firms to make informed business decisions based on in-depth assessment of competitors in development and on the market. Prior to that, Deborah was head of CI for Genentech, and led competitive intelligence initiatives to investigate key competitors (product and company-level), evaluate revenue impact of competition, and assess full market landscapes. Sandra Waugh Ruggles is a healthcare innovator and strategic marketer. Currently focused on consulting for small companies seeking to design and develop novel medical devices, Sandy was formerly in strategic marketing at Acclarent (part of J&amp;J). She holds a PhD from UCSF in Biophysics, and was a Thomas Fogarty Fellow at the Stanford Biodesign program. Her first company, Catalyst Biosciences was formed in part from her thesis at UCSF, and is now a clinical stage, NASDAQ listed company. Anatol Kreitzer, PhD is an Associate Investigator at the Gladstone Institute of Neurological Disease and Associate Professor of Physiology and Neurology at UCSF. Dr. Kreitzer’s research focuses on the disordered physiological processes associated with Parkinson’s disease. He is an expert in the emerging field of optogenetics—the application of genetic and optical techniques to remotely control brain cells in animals. Dr. Kreitzer earned his PhD in neurobiology at Harvard University. He conducted postdoctoral research at Stanford University with Dr. Robert Malenka until 2007, when he established his laboratory at Gladstone.

BCBS: Business Strategy 1 - Value Proposition (Deborah Dauber)